作者
Paul England

Dr Paul England

高级专业支持律师

Read More
Matthew Royle

Matthew Royle, Ph.D.

合伙人

Read More
作者
Paul England

Dr Paul England

高级专业支持律师

Read More
Matthew Royle

Matthew Royle, Ph.D.

合伙人

Read More

2018年12月13日

Synapse - November/December 2018

This month on Synapse

Biosimilars - pricing and reimbursement and the competitive landscape

Our Taylor Wessing and Willke Farr & Gallagher experts discuss the pricing and reimbursement process for biosimilars in the US, the UK, France, Germany and the Netherlands, and the line between competition and a breach of antitrust rules as it applies to this market.

Infringement of second medical use patents in the UK: pregabalin in the Supreme Court

Paul England and Matthew Royle explain the reasoning of the UK Supreme Court Warner-Lambert decision and its implications for how infringement of second medical use claims will be assessed in the UK.

The grant of an SPC for a new therapeutic application

Judith Krens and Marthe Riewald reports a decision from the Netherlands in which a new therapeutic application of a known active substance could qualify for an SPC.

Prescription to patenting: cannabis-derived medicinal products

Paul England examines recent developments allowing prescription of medicinal cannabis for certain conditions.

Can a decision on the UPC be expected soon?

Paul England looks at recent speculation about the Unified Patent Court and Unitary Patent.

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

酒店与休闲

Synapse - December 2019

2019年12月19日

作者

点击此处了解更多
酒店与休闲

Synapse - October 2019

2019年10月25日

作者 Dr Paul England

点击此处了解更多
酒店与休闲

Synapse - September 2019

2019年9月27日

作者

点击此处了解更多